Get a full analysis report for any ticker →

SECTOR COVERAGE

Analyst Ratings & Price Targets

50 STORIES · UPDATED 19H AGO

Wall Street's upgrades and downgrades move stocks first and get justified later. We track the rating and price-target changes that matter and add the independent read consensus leaves out — whether the call is early, late, or already priced in.

Top StoryTTD

The Trade Desk Drops 20% in 10 Days, Analyst Warns of 50% Downside

The Trade Desk fell 20% over 10 consecutive losing sessions as an analyst flagged 50% more downside, with 24.2% short float and 3.0% YoY revenue growth pointing to a structural re-rating rather than a temporary dip.

NLYAnalysis

Annaly CEO Sold $1.1M as Fed Shift Spooks Analysts

Annaly Capital Management posted its fourth consecutive earnings beat in Q2 2026 — the strongest of the streak — yet its CEO sold $1.1 million in stoc…

CELHAnalysis

Celsius Insiders Buy $1.83M as Analysts Issue Sell

Celsius Holdings missed Q2 earnings after three consecutive beats, triggering a fresh Sell rating from Wall Street Zen. Three company insiders respond…

OKLOBrief

Oklo Wins DOE Milestone With Analysts Split Between $41 and $100

Oklo secured an undisclosed DOE milestone that reignited bullish $100 price target talk, but UBS cut to $41 and a Seeking Alpha analyst stayed bearish…

GWREAnalysis

Guidewire Execs Sell $23.7M as Analysts See 42% Upside

Five Guidewire Software executives sold $23.68 million in stock at $144.47 between September 8 and 21, with CEO Michael Rosenbaum accounting for $10.4…

RRCAnalysis

Four Straight Beats Leave RRC 20% Below Analyst Targets

Range Resources has delivered four consecutive earnings beats with the positive surprise growing each quarter, yet the stock sits at $38.32 — below th…

AQNAnalysis

Algonquin Power Gets Outperform Despite $6.65B Debt

Huntington Capital initiated Algonquin Power with an Outperform rating, citing four consecutive quarters of EPS beats and a $3.2 billion simplificatio…

PONYAnalysis

Pony AI Insiders Exit at $6.90 as Analysts Eye $20

Four Pony AI executives—the CTO, CFO, and two vice presidents—sold shares at $6.86–$6.93 in late June 2026. The stock trades at $6.88 today, unchanged…

AGIAnalysis

Alamos Gold Insider Sells as Analysts See 31% Upside

An Alamos Gold insider filed to sell 9,700 shares while the stock sits more than $11 below the $46.25 consensus analyst price target and the company h…

WULFAnalysis

TeraWulf CEO Sells Again as Analysts Eye 100% Upside

TeraWulf's CEO sold $6 million in stock across June and August, exiting at prices 36% below his initial sale, while Wall Street consensus implies more…

RYANAnalysis

Ryan Specialty CRO Sells at $40: Analysts Targeting $50

Ryan Specialty's co-president and CRO Brendan Mulshine sold $1.62 million in stock at $40.51 in early September, weeks after the company posted a 23.3…

ERIEAnalysis

Erie Gets Buy Upgrade as Stock Extends 2026 Decline

A Buy upgrade of Erie Indemnity sparked a brief 3.6% gain that evaporated within days, leaving the stock down on the year despite strong free cash flo…

AVTRAnalysis

AVTR Stock Clears Analyst Target on 0.5% Revenue Growth

Avantor shares trade at $15.44—above the consensus analyst price target of $14.66—after a three-quarter streak of accelerating adjusted EPS beats. Yet…

ACHRAnalysis

Archer Insiders Sold at $6.40; Analysts See $10.61

Four Archer Aviation executives exercised stock options and sold $1.44 million in shares at $6.31–$6.41 in mid-August, days after the company's Boeing…

HALOAnalysis

Halozyme CEO Sells $6M More as HALO Tops Analyst Target

Halozyme Therapeutics CEO Helen Torley sold $6.44 million of company stock across three consecutive days ending September 11, 2026, at prices between …

PATHBrief

UiPath Analysts Raise Targets After Worst Week in 4 Months

Multiple analysts raised UiPath price targets despite the stock's worst weekly decline in four months, but persistent skepticism about concrete AI mon…

AMBAAnalysis+32%

Ambarella Surges 32% on Upgrade, but CEO Sold at $90

Ambarella surged 32% after Rosenblatt upgraded the chip designer to "pure play on Physical AI," citing four consecutive EPS beats and 13.2% trailing r…

FNFAnalysis

FNF Insiders Net Sell $7M as Analysts Target 39% Upside

Fidelity National Financial trades at 7.6 times forward earnings with Wall Street analysts targeting a 39% premium to today's price—yet company inside…

PACSAnalysis

PACS Insiders Net $35.7M as Analyst Target Sits at $59

PACS Group's co-founder and CEO has made 20 consecutive open-market sales of company stock since mid-August 2026, all at prices between $42 and $45 — …

SXTBrief

Sensient Technologies Upgraded to Strong Buy at 26x Earnings

Sensient Technologies received a Strong Buy upgrade backed by 11.6% revenue growth to $1.7bn, but negative trailing free cash flow at a 25.9x forward …

MNDYAnalysis

MNDY Insiders Sell at $100 as Analysts Eye $109 Target

Director Aviad Eyal and Chief Revenue Officer James Case George sold a combined $263,000 in monday.com shares at $94 to $101 between August 31 and Sep…

OIIAnalysis

Oceaneering Trades Above Analyst Target After Rally

Oceaneering International filed an investor disclosure on September 8 as its shares trade at $51.09 — above the $46 analyst consensus price target and…

PRAXAnalysis-12%

PRAX Falls 12% After Trial Setback Following Analyst Boost

Praxis Precision Medicines dropped 12% after-hours following a trial setback, just three days after analysts issued upgrades projecting 91% upside. Wi…

PAYPAnalysis+6.3%

PayPay Shares Rise 6.3% as Analyst Target Sits at $24.87

PayPay Corporation shares rose 6.3% in recent trading, yet institutional investors collectively own just 4.4% of shares outstanding — a stark disconne…

GRABAnalysis

Grab Stock Hits 52-Week Low as Analysts See 71% Upside

Grab Holdings shares fell to a 52-week low last week even as the company has beaten analyst EPS estimates by 200% to 363% in each of its last three re…

PLSEAnalysis

Pulse Bio COO Buys Above Analyst Target at All-Time High

Pulse Biosciences COO bought nearly $200K of stock above analyst targets as shares hit all-time highs, signaling conviction in the company's cardiac c…

WEXAnalysis

WEX CEO Sells $5.3M as Stock Beats Analyst Target

WEX Inc. has beaten analyst EPS estimates for four consecutive quarters with revenue growth of 14.2% year-over-year, and its stock has risen 15.4% sin…

CNRAnalysis

Core Natural Resources: Analysts Eye $109 Despite 5% Drop

Core Natural Resources shares fell 5.1% after a 292.3% Q2 earnings beat — yet analysts still carry a consensus price target of $109.5, roughly 10% abo…

BFAMAnalysis

Bright Horizons Falls Below Insider Sales Amid Analyst Gap

Bright Horizons has fallen to $70.25, below all insider sales from the past five weeks, despite posting four consecutive earnings beats and generating…

INTAAnalysis

Intapp Shares Surge Past Analyst Target as Insiders Sell

Intapp shares climbed 3.9% on September 4, 2026, lifting INTA to $41.89 — more than 6% above the $39.43 analyst consensus price target — as investors …

PATHBrief-7%

UiPath Drops 7% as Analyst Says SaaS Recovery Is Priced In

UiPath stock tumbled more than 7% overnight after Seeking Alpha downgraded the shares, arguing the SaaS recovery thesis is fully priced in at current …

PCORAnalysis

Procore Insiders Sell as Analysts Call Stock Undervalued

Procore earned a Zacks analyst upgrade and undervalued designation on September 4, the same day a director sold shares, extending a 90-day insider sel…

HCCAnalysis

Warrior Met Coal CEO Sells $10.75M Above Analyst Target

Warrior Met Coal's CEO unloaded $10.75 million in company stock over six days at prices at or above the analyst consensus price target — just weeks af…

RLIAnalysis

Jefferies Cuts RLI as Stock Runs Past Analyst Targets

RLI Corp. has beaten Wall Street earnings estimates in each of the four most recent quarters, yet Jefferies has downgraded the specialty insurer on va…

IMAXAnalysis

StoneX Sees Record Q3 as IMAX Stock Hits Analyst Ceiling

StoneX reiterated a Buy on IMAX and forecast a record third quarter—a call that lands just as the stock trades at $51.70 against an analyst consensus …

PSNAnalysis

Parsons Insider Buys $960K as Analysts Turn Cautious

George L. Ball bought 20,000 Parsons shares at $47.97 on August 7, the only open-market insider purchase in 90 days with no selling in that window. TT…

AGNCAnalysis

AGNC CFO Sells at Analyst Target After Earnings Beats

AGNC Investment Corp. CFO Bernice Bell sold 20,000 shares across three transactions in July and August at $11.00 to $11.10, at or above the $11.06 ana…

HUBSBrief+7.9%

HubSpot Surges 7.9% on AI Hype, Then Gets Downgraded

HubSpot surged 7.9% on AI-driven 2026 optimism before Seeking Alpha downgraded the stock citing uncertain near-term demand, with a GF Score of 66 and …

ENVAAnalysis

Enova Chairman Sells $23.5M Against $277 Analyst Target

Enova International's Executive Chairman David Fisher sold $23.54 million in stock over 90 days with zero open-market purchases, while analyst consens…

SAILAnalysis

SailPoint Hits Analyst Target While CEO Sold Below It

SailPoint shares crossed the $19.90 average analyst consensus this week, the same price level where its chief accounting officer sold in August, while…

IPBrief

International Paper Hits 52-Week Low, Sell Rating Confirmed

International Paper fell to a 52-week low of $40.78 as a Seeking Alpha analyst confirmed a Sell rating, arguing H2 2026 recovery expectations are too …

MEDPAnalysis

Medpace: Six Insiders Sell $84M Above Analyst Target

Six Medpace insiders, including CEO Troendle, sold $84.29 million in shares since late July at prices between $585 and $625, all above the $581.83 ana…

PAYPAnalysis

PayPay Stock Surges as Wolfe Cuts Price Target to $21

Wolfe Research maintained a Buy rating on PayPay Corporation on August 25 while cutting its price target to $21, even as the stock extended a 7.84% pr…

FDSAnalysis

FactSet Beats Again, but Trades 20% Above Analyst Target

FactSet Research Systems has delivered three consecutive EPS beats, most recently $4.53 against a $4.45 estimate, with shares rising 5.2% since the Ju…

CELHBrief

Celsius Holdings Drops Again as Analysts Cut Targets on UK Ban Risk

Celsius Holdings posted a second consecutive week of losses as multiple analyst price target cuts piled on top of UK regulatory risk, with 13.8% of th…

UGPAnalysis

Ultrapar Tops Analyst Target. Institutions Hold Only 5.6%

Ultrapar Participações has beaten EPS estimates in each of the past four quarters, with Q2 2026 delivering a 25.3% surprise on 27.8% revenue growth an…

UGPAnalysis

Ultrapar Tops Analyst Target Built on Four Underestimates

Ultrapar's Q2 2026 EPS of $0.297 beat consensus by 25.3%, the widest positive surprise in a four-quarter beat streak, driving UGP shares above the $6.…

TXGAnalysis

10x Genomics Trades Past Analyst Target, Atera Test Looms

An analyst upgraded 10x Genomics this week and declared the Atera turnaround "real," yet shares already trade at $65.12, above the $49.54 consensus pr…

TXGAnalysis

10x Genomics Clears Analyst Target, Insiders Keep Selling

10x Genomics shares have rallied to $65.12, surpassing the analyst consensus price target of $49.54, after August earnings prompted upgrades citing At…

EGOAnalysis

Eldorado Gold Closes Foran, 12.6% Above Analyst Target

Eldorado Gold Corporation closed its acquisition of Foran Mining against a backdrop of negative free cash flow of $454 million and $1.21 billion in ne…

Keep going

Your move

Run this same teardown on a stock you actually own.

Drop in any ticker and get an institutional-grade report in about 60 seconds — the full DCF, an earnings-quality score, and the red flags buried deep in the filing. No signup, no card.

Run a free report →
  • DCF valuation with bull & bear cases
  • Earnings-quality score from 0–100
  • Red-flag scan across the 10-K
  • Peer multiples & a fair-value range